Drug & Medical Device Litigation Conference 2019 - Presented by American Conference Institute (ACI)

Dechert is proud to sponsor ACI's Drug and Medical Device Litigation Conference 2019, taking place December 10 - 11 at the New York Marriott Marquis.

ACI’s Drug and Medical Device Litigation conference brings together an exceptional in-house presence on the faculty, the top defense firms representing pharmaceutical and medical device companies, experienced jurists from around the country, the FDA, and the DOJ. Designed for both networking and masters-level strategy sharing, this is the leading forum at which to learn winning life sciences products liability litigation strategies.

For more information please visit the conference website.

Dechert Sessions:

December 10, 2019
1:00 p.m.
Dechert panelist: Sara B. Roitman, Counsel

MDL CASE STUDY: Analyzing the Unique Nuances of Today’s Three Most Significant MDLs

This panel will examine three MDLs that the pharmaceutical and medical device industries are very closely watching — In Re: National Prescription Opiate Litigation (MDL No. 2804 (opioids), Johnson & Johnson Talcum Powder MDL 2738 (talc); and 3M Company Combat Arms Earplug MDL 2885 (3M combat ear plugs). The panelists will compare and contrast the unique elements of these MDLs, and provide insights on:

• Each of their distinctive litigation challenges.
• Successful plaintiff tactics and defense strategies.
• Notable judicial rulings and key takeaways.

December 10, 2019
2:00 p.m.
Dechert panelist: Hayden Coleman, Partner

Developing Techniques for Managing MDL Complexities: Obtaining Tools for Identifying, Controlling and Reducing Meritless Claims

Topics include:

• Examining various techniques for managing MDL complexities.
• Using social media and online investigation tools to identify and control meritless claims early on.
• Effectively utilizing screening orders, lone pine orders and lexecon waivers.
• Developing tactics for approaching negotiations with plaintiffs’ counsel throughout the MDL process.
• Devising strategies for managing remand of remaining cases after MDL settlement.
• The use of “Science Days” to educate MDL judges on key scientific issues.